A Single-arm Clinical Trial Using Patient-derived Tumor Tissue Fragment Models for Drug Sensitivity Testing to Guide Treatment in Previously Treated Cancers

Clinical trial NCT07264803 · RECRUITING

Trial details

NCT number: NCT07264803
Sponsor: Qilu Hospital of Shandong University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Tumor Malignancies Solid Tumor Cancer

Start date: 2024-03-01
Primary completion: 2027-12-30
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.